Tissue Agnostic Therapy
“Guided Missile” Drugs and Immune Checkpoint BlockadeThe dawning of the era of personalized medicine in the 21st century also holds out new prospects for patients. One can now direct...
“Guided Missile” Drugs and Immune Checkpoint BlockadeThe dawning of the era of personalized medicine in the 21st century also holds out new prospects for patients. One can now direct...
The Long History of Immune Checkpoint Inhibitors It does not diminish Jim Allison’s remarkable achievements to note that scientists have long known that tumors employ mechanisms to block the...
Dead Cell DebrisReactions to rituximab therapyTumor lysis syndrome (TLS) is another, more serious reaction that has been reported following rituximab therapy. In a sense tumor lysis syndrome is a...
The Fourth ModalityCancer immunotherapy is a vast topic, the subject of tens of thousands of scientific articles, over 750 of which are randomized trials. It was Science magazine’s breakthrough...
Bacille Calmette-Guérin (BCG)Scientists at the University of California, Los Angeles (UCLA) have commented: “Bacillus Calmette-Guérin is one of the most successful immunotherapies in cancer...
In this episode of The Moss Report Podcast, Ralph Moss speaks with Will LaValley, MD, about his personalized approach to treating cancer. Dr. LaValley is a leading practitioner of Molecular...
Keytruda immunotherapy for cancer is better than chemo in the treatment of Merkel cell cancer. So says a recent clinical trial of this immune treatment at Johns Hopkins Medicine, Baltimore....
IMMUNE THERAPY PUTS STAGE IV BREAST CANCER INTO REMISSION Scientists at the National Cancer Institute (NCI) in Bethesda, Maryland, have reported putting a woman with advanced, stage IV breast...
Ralf Kleef, MD, Vienna, Austria TRIPLE NEGATIVE BREAST CANCER: A HIGHLY SIGNIFICANT FINDING In mid-September 2018, the medical journal Integrative Cancer Therapies (SAGE), published a...
HISTORY OF IMMUNE CHECKPOINT INHIBITION Photo: Dr. Lloyd J. Old and Helen Coley Nauts (c. 1980) In February of 2017, for the second year in a row, the American Society of Clinical Oncology (ASCO)...
Immune Checkpoint Inhibitors: One of the most important questions about ICI therapy is who will respond to this new type of treatment. A recent paper from the University of Texas M.D. Anderson...
“Immunotherapy: The Battle Within” is a documentary film produced by Moss Reports and the Center for Integrative Oncology. The film is about the past, present and future of cancer immunotherapy,...